Design, Molecular Docking, Synthesis and Antiproliferative Evaluation of New 5-Aminoisatin Derivatives

Authors

  • Noor waleed ibrahim Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad,Iraq.
  • Monther Faisal Mahdi Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad,Iraq
  • Ayad M.R. Raauf 3Department of Pharmaceutical Chemistry, College of Pharmacy, Farahidi University, Baghdad,Iraq

DOI:

https://doi.org/10.31351/vol34iss3pp29-41

Keywords:

5-Aminoisatin, ADME, Docking, GOLD, Lipinski rule

Abstract

Two series of compounds derived from 5-aminoisatin were synthesized, Schiff bases IIa-c and ureido derivatives of 5-aminoisatin Schiff bases IIIa-c& IVa-c.The proposed compounds were successfully synthesized and purified; they were characterized and identified using: melting point, IR spectroscopy, 1H-NMR and13C-NMR; The in vitro cytotoxic activity of these novel compounds was tested and molecular docking-based in silico tyrosine kinase selectivity via GOLD Suite  (v.5.7.1); Our docking results and the experimental data (In vitro study)  are in good accord since the compound IIIa shows the highest docking result and at the same time showing a promising cytotoxic activity among the tested compounds when tested against (A549) cancer cell lines by the MTT assay in comparison with erlotinib. Additionally, ADME studies were conducted to determine which of them are candidates for oral administration, as well as their absorption location, bioavailability, topological polar surface area, and drug-likeness.

How to Cite

1.
waleed ibrahim N, Monther Faisal Mahdi, Ayad M.R. Raauf. Design, Molecular Docking, Synthesis and Antiproliferative Evaluation of New 5-Aminoisatin Derivatives. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Sep. 20 [cited 2025 Sep. 20];34(3):29-41. Available from: https://www.bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2821

Publication Dates

Received

2023-07-26

Revised

2023-08-09

Accepted

2025-04-07

Published Online First

2025-09-20

References

Rahul H. Profile of similarity of electron withdrawing structure towards analgesic-anti-inflammatory activity of the novel isatin analogue: design and implementation of phase I drug discovery. International physiology journal.2018; 1(2): 7.

Tariq A, Fazal R, Roh U, Asmat U, Fazal H, Farman UK, Mehwish K, Noor SK, Mudassir I. Synthesis and biological evaluation of isatin based thiazole derivatives. BJSTR. 2020 July; 28(5).

Vinod U, Harun P, Bijal P, Sanjay B. Benzofurano-isatins: Search for antimicrobial agents. Arabian Journal of Chemistry. 2017; 10: S389–S396.

Marzieh RK, Ahmad MF, Aref M, Alireza A. Synthesis and evaluation of anticonvulsant activity of (Z)-4-(2-oxoindolin-3-ylideneamino)-N-phenylbenzamide derivatives in mice. Research in Pharmaceutical Sciences. 2018 June; 13(3): 262-272.

Reem W, Aliyah A, Maha M, Adam K, Gary P, Mohamed A. New isatin–indole conjugates: synthesis, characterization, and a plausible mechanism of their in vitro antiproliferative activity. Drug Design, Development and Therapy. 2020:(14): 483–495.

Huda SS , Hatem AA, Iman SI, Amany ZM, Ali H, Md A, Motiur RAFM. Synthesis of novel potent biologically active N-benzylisatin-aryl hydrazones in comparison with lung cancer drug ‘gefitinib’. Appl. Sci. 2020 May; 10(3669).

Ravi J, Kiran G, Sarangapani M, Sriram R. Synthesis, in vivo anti-inflammatory activity, and molecular docking studies of new isatin derivatives. International Journal of Medicinal Chemistry. 2016.

Ozougwu, Jevas C. The Role of Reactive Oxygen Species and Antioxidants in Oxidative Stress. International Journal of Research in Pharmacy and Biosciences. 2016 June; 6(3): 1-8.

Aleti R, Srinivas MM. Synthesis, characterization, and anthelmintic activity of novel benzothiazole derivatives containing indole moieties. Asian J Pharm Clin Res. 2019; 3(12): 321-325.

Vaishali A, Katrin S, Mehak A, Ashif I, Ajay K, Saumya S, Anjana P, Satwinderjeet K, Hardeep ST. Drug targets in cellular processes of cancer: from nonclinical to preclinical models. Singapore: Springer; 2020.

Min L, Jianfeng J, Ruiqi W. Screening drug target combinations in disease-related molecular networks. BMC Bioinformatics. 2019; 20(7):129-151.

Saad HA. Synthesis, characterization, anticancer activity, and molecular docking of some new sugar hydrazine and arylidene derivatives. Arabian Journal of Chemistry. 2020; 13: 4771–4784.

G. Mahesh Kumar, K. Arun Kumar, P. Rajashekar Reddy, J. Tarun Kumar. A novel approach of tumor detection in brain using MRI scan images. Research J. Pharm. and Tech. 2020; 13(12):5914-5918.

Suhas SA, Santosh KS, Kiran AW. In vitro antioxidant potential and anticancer activity of ceratophyllum demersum Linn. extracts on HT-29 human colon cancer cell line. Research J. Pharm. and Tech. 2021; 14(1):28-36.

Aguslina K, Siswandono S, I Ketut S. Synthesis and Cytotoxic Activity of N-(4-bromo)-benzoyl-N’phenylthiourea and 4-(tert-butyl)-N-benzoylurea on Primary Cells of HER2-Positive Breast Cancer. Research J. Pharm. and Tech. 2021; 14(3):1195-1200.

Zuan-Fu L, Patrick CM. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. Journal of Hematology & Oncology. 2019; 12(134).

Jean- Christophe M, Sarah- Jane D, Mark AD. Non- genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer. 2020 October 8.

Jinxin L, Jianfeng P, Luhua L. A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion protein. Communications Biology. 2020; 3: 18.

S. Ramachandran, N. Vimeshya, K. Yogeshwaran, Binoy Varghese Cheriyan, M. Vijey Aanandhi. 6Molecular docking studies, synthesis, characterisation, and evaluation of azetidine-2-one derivative. Research J. Pharm. and Tech. 2021; 14(3):1571-1575.

Samuel MD, Adeboye AO, Jamiu AA, Ajiboye OD, Tolulope OO Olaposi OI. Exploring receptor tyrosine kinases inhibitors in cancer treatments. Egyptian Journal of Medical Human Genetics; 2019: 20(35).

Y. E. Matiichuk, T. I. Chaban, V. V. Ogurtsov, I. G. Chaban, V. S. Matiychuk. Antitumor Properties of Novel 2-(1H-Benzoimidazol-2-yland 2-Benzothiazol-2-yl)-3-(5-phenylfuran-2-yl)-acrylonitriles Derivatives. Research J. Pharm. and Tech. 2020; 13(8):3690-3696.

Kamaleddin HE Tehrani, Maryam H, M H, Farzad K , Shohreh M. Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins. Chinese Chemical Letters. 2016; 27: 221–225 .

Rahul RK , Grace SC, Hsiao-CW, Chao-WY, Chiung-HH, On Lee , Chih-HC, Chrong-SH, Ching-HK, Nien-TC, Mai-WL,Ling-MW, Yen-CC , Tzong-HH, Chia-NC, Hui-CH, Hui CL,Ying-CS, Shuen-HC, Hsiang-WT, Chih-PL, Chia-MT, Tsan-LH, Yuan-JT, Ji-WC. Synthesis and structure–activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry .2010; 18: 4674–4686.

Shakila BS, Krishnamoorthy G, Senthamarai R, Mohamed JMS. Synthesis, spectral characterization and anticancer activity of novel pyrimidine derivatives. Research J. Pharm. and Tech. 2020; 13(12):6243-6247.

Mustafa MA, Monther FM, Ayad MRR. Synthesis, anti-inflammatory, molecular docking and ADME studies of new derivatives of ketoprofen as cyclooxygenases inhibitor. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2019; 19(4).

Sarah SI, Monther FM, Basma MA. Molecular drug design, synthesis and antibacterial study of novel 4-oxothiazolidin-3-yl derivatives. Al-Mustansiriyah Journal of Pharmaceutical Sciences. 2020 June ; 20(2):1- 10.

Daina A, Zoete V. A BOILED‐Egg to predict gastrointestinal absorption and brain penetration of small molecules.ChemMedChem. 2016 Jun 6; 11(11):1117-21.

Samuel AE, James S, Sarel FM, Alan C. Prioritization of anti‑malarial hits from nature: chemo‑informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti‑malarial drugs. Malar J, 2016;15:50.

Sebaugh JL. Guidelines for accurate EC50/ IC50 estimation. Pharm Stat. 2011;10(2):128–34.

Downloads

Published

2025-09-20